The Role of Interneurons in Autism and Tourette Syndrome

Trends in Neurosciences

Volumn 40, Issue 7, 2017, Pages 397-407

  Rapanelli, Maximiliano ^a,b   Frick, Luciana Romina ^a,b   Pittenger, Christopher ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

autism; cortex; interneurons; striatum; Tourette syndrome

Indexed keywords

AUTISM; CELL LOSS; COMORBIDITY; CORPUS STRIATUM; CORTICOSTRIATAL CIRCUIT; DISEASE MODEL; DOWN REGULATION; GABAERGIC SYSTEM; GABAERGIC TONE; GENE EXPRESSION; GENE MUTATION; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTERNEURON; MOLECULAR PATHOLOGY; NERVE CELL INHIBITION; NERVE TRACT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; ANIMAL; BRAIN; GENETICS; PHYSIOLOGY;

ANIMALS; AUTISTIC DISORDER; BRAIN; HUMANS; INTERNEURONS; NEURAL PATHWAYS; TOURETTE SYNDROME;

EID: 85019972684     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2017.05.004     Document Type: Review

References (89)

1. Bartolini, G., et al. Integration of GABAergic interneurons into cortical cell assemblies: lessons from embryos and adults. Neuron 79 (2013), 849–864.
2. Petilla Interneuron Nomenclature Group, et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat. Rev. Neurosci. 9 (2008), 557–568.
3. Watson, C., et al. The Mouse Nervous System. 2012, Elsevier Academic Press.
4. Zingg, B., et al. Neural networks of the mouse neocortex. Cell 156 (2014), 1096–1111.
5. Markram, H., et al. Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 5 (2004), 793–807.
6. Kepecs, A., Fishell, G., Interneuron cell types are fit to function. Nature 505 (2014), 318–326.
7. Tricoire, L., Vitalis, T., Neuronal nitric oxide synthase expressing neurons: a journey from birth to neuronal circuits. Front. Neural Circuits, 6, 2012, 82.
8. Helie, S., et al. Learning robust cortico-cortical associations with the basal ganglia: an integrative review. Cortex 64 (2015), 123–135.
9. Fuccillo, M.V., Striatal circuits as a common node for autism pathophysiology. Front. Neurosci., 10, 2016, 27.
10. Cox, S.M., et al. Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes. Neuroimage 109 (2015), 95–101.
11. Ahmari, S.E., Dougherty, D.D., Dissecting OCD circuits: from animal models to targeted treatments. Depress. Anxiety 32 (2015), 550–562.
12. Calabresi, P., et al. Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat. Neurosci. 17 (2014), 1022–1030.
13. Xenias, H.S., et al. Are striatal tyrosine hydroxylase interneurons dopaminergic?. J. Neurosci. 35 (2015), 6584–6599.
14. Lim, S.A., et al. Striatal cholinergic interneuron regulation and circuit effects. Front. Synaptic Neurosci., 6, 2014, 22.
15. Jin, X., Costa, R.M., Shaping action sequences in basal ganglia circuits. Curr. Opin. Neurobiol. 33 (2015), 188–196.
16. Dehghani, N., et al. Dynamic balance of excitation and inhibition in human and monkey neocortex. Sci. Rep., 6, 2016, 23176.
17. Kubota, Y., et al. The diversity of cortical inhibitory synapses. Front. Neural Circuits, 10, 2016, 27.
18. Petersen, C.C., Crochet, S., Synaptic computation and sensory processing in neocortical layer 2/3. Neuron 78 (2013), 28–48.
19. Pronneke, A., et al. Characterizing VIP neurons in the barrel cortex of VIPcre/tdTomato mice reveals layer-specific differences. Cereb. Cortex 25 (2015), 4854–4868.
20. Naka, A., Adesnik, H., Inhibitory circuits in cortical layer 5. Front. Neural Circuits, 10, 2016, 35.
21. Fu, Y., et al. A cortical circuit for gain control by behavioral state. Cell 156 (2014), 1139–1152.
22. Kim, J., et al. Layer 6 corticothalamic neurons activate a cortical output layer, layer 5a. J. Neurosci. 34 (2014), 9656–9664.
23. Pi, H.J., et al. Cortical interneurons that specialize in disinhibitory control. Nature 503 (2013), 521–524.
24. Pfeffer, C.K., et al. Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons. Nat. Neurosci. 16 (2013), 1068–1076.
25. Gonzales, K.K., Smith, Y., Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions. Ann. N. Y. Acad. Sci. 1349 (2015), 1–45.
26. Tecuapetla, F., et al. Complementary contributions of striatal projection pathways to action initiation and execution. Cell 166 (2016), 703–715.
27. Straub, C., et al. Principles of synaptic organization of GABAergic interneurons in the striatum. Neuron 92 (2016), 84–92.
28. Faust, T.W., et al. Neostriatal GABAergic interneurons mediate cholinergic inhibition of spiny projection neurons. J. Neurosci. 36 (2016), 9505–9511.
29. Kosillo, P., et al. Cortical control of striatal dopamine transmission via striatal cholinergic interneurons. Cereb. Cortex 26 (2016), 4160–4169.
30. Sciamanna, G., et al. Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons. Sci. Rep., 5, 2015, 16742.
31. Wall, N.R., et al. Differential innervation of direct- and indirect-pathway striatal projection neurons. Neuron 79 (2013), 347–360.
32. Association, A.P, Diagnostic and Statistical Manual of Mental Disorders. 2013, American Psychiatric Association.
33. C.D.C, Prevalence and characteristics of autism spectrum disorder among children aged 8 years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. Surveill. Summ. 63 (2016), 1–21.
34. Scharf, J.M., et al. Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov. Disord. 30 (2015), 221–228.
35. Capuano, A., Valeri, G., Tics and Tourette syndrome in autism spectrum disorder. Mazzone, L., Vitiello, B., (eds.) Psychiatric Symptoms and Comorbidities in Autism Spectrum Disorder, 2016, Springer International Publishing, 93–109.
36. Hanks, C.E., et al. Social deficits and autism spectrum disorders in Tourette's syndrome. Curr. Dev. Disord. Rep. 2 (2015), 285–292.
37. Kalyva, E., et al. A review of co-occurrence of autism spectrum disorder and Tourette syndrome. Res. Autism Spectr. Disord. 24 (2016), 39–51.
38. Eapen, V., et al. Comorbidities, social impact, and quality of life in Tourette syndrome. Front. Psychiatry, 7, 2016, 97.
39. Worbe, Y., et al. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome. Brain 138 (2015), 472–482.
40. Greene, D.J., et al. Brain structure in pediatric Tourette syndrome. Mol. Psychiatry, 2016, 10.1038/mp.2016.194 Published online October 25, 2016.
41. Muller-Vahl, K.R., et al. Tics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms. BMC Neurosci., 15, 2014, 6.
42. Conti, E., et al. Network over-connectivity differentiates autism spectrum disorder from other developmental disorders in toddlers: a diffusion MRI study. Hum. Brain Mapp. 38 (2017), 2333–2344.
43. Schuetze, M., et al. Morphological alterations in the thalamus, striatum, and pallidum in autism spectrum disorder. Neuropsychopharmacology 41 (2016), 2627–2637.
44. Langen, M., et al. Changes in the development of striatum are involved in repetitive behavior in autism. Biol. Psychiatry 76 (2014), 405–411.
45. Mataix-Cols, D., et al. Familial risks of Tourette syndrome and chronic tic disorders. A population-based cohort study. JAMA Psychiatry 72 (2015), 787–793.
46. Georgitsi, M., et al. The genetic etiology of Tourette syndrome: large-scale collaborative efforts on the precipice of discovery. Front. Neurosci., 10, 2016, 351.
47. Church, J.A., Schlaggar, B.L., Pediatric Tourette syndrome: insights from recent neuroimaging studies. J. Obsessive Compuls. Relat. Disord. 3 (2014), 386–393.
48. Lerner, A., et al. Widespread abnormality of the gamma-aminobutyric acid-ergic system in Tourette syndrome. Brain 135 (2012), 1926–1936.
49. Kataoka, Y., et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J. Comp. Neurol. 518 (2010), 277–291.
50. Lennington, J.B., et al. Transcriptome analysis of the human striatum in Tourette syndrome. Biol. Psychiatry 79 (2016), 372–382.
51. Robinson, E.B., et al. Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population. Nat. Genet. 48 (2016), 552–555.
52. Gaugler, T., et al. Most genetic risk for autism resides with common variation. Nat. Genet. 46 (2014), 881–885.
53. de la Torre-Ubieta, L., et al. Advancing the understanding of autism disease mechanisms through genetics. Nat. Med. 22 (2016), 345–361.
54. Puts, N.A.J., et al. Reduced GABA and altered somatosensory function in children with autism spectrum disorder. Autism Res. 10 (2017), 608–619.
55. Port, R.G., et al. Exploring the relationship between cortical GABA concentrations, auditory gamma-band responses and development in ASD: evidence for an altered maturational trajectory in ASD. Autism Res. 10 (2017), 593–607.
56. Robertson, C.E., et al. Reduced GABAergic action in the autistic brain. Curr. Biol. 26 (2016), 80–85.
57. Harada, M., et al. Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. J. Autism Dev. Disord. 41 (2011), 447–454.
58. Gaetz, W., et al. GABA estimation in the brains of children on the autism spectrum: measurement precision and regional cortical variation. Neuroimage 86 (2014), 1–9.
59. Zurcher, N.R., et al. A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities. Neurosci. Biobehav. Rev. 52 (2015), 56–73.
60. Ariza, J., et al. The number of chandelier and basket cells are differentially decreased in prefrontal cortex in autism. Cereb. Cortex, 2016, 10.1093/cercor/bhw349 Published online November 24, 2016.
61. Hashemi, E., et al. The number of parvalbumin-expressing interneurons is decreased in the medial prefrontal cortex in autism. Cereb. Cortex 27 (2017), 1931–1943.
62. Nelson, S.B., Valakh, V., Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron 87 (2015), 684–698.
63. McBride, S.D., Parker, M.O., The disrupted basal ganglia and behavioural control: an integrative cross-domain perspective of spontaneous stereotypy. Behav. Brain Res. 276 (2015), 45–58.
64. Xu, M., et al. Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 893–898.
65. Xu, M., et al. Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming. Neuroscience 324 (2016), 321–329.
66. Jaramillo, T.C., et al. Novel Shank3 mutant exhibits behaviors with face validity for autism and altered striatal and hippocampal function. Autism Res. 10 (2017), 42–65.
67. Duffney, L.J., et al. Autism-like deficits in Shank3-deficient mice are rescued by targeting actin regulators. Cell Rep. 11 (2015), 1400–1413.
68. Peca, J., et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472 (2011), 437–442.
69. Gogolla, N., et al. Sensory integration in mouse insular cortex reflects GABA circuit maturation. Neuron 83 (2014), 894–905.
70. Penagarikano, O., et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147 (2011), 235–246.
71. Jurgensen, S., Castillo, P.E., Selective dysregulation of hippocampal inhibition in the mouse lacking autism candidate gene CNTNAP2. J. Neurosci. 35 (2015), 14681–14687.
72. Varea, O., et al. Synaptic abnormalities and cytoplasmic glutamate receptor aggregates in contactin associated protein-like 2/Caspr2 knockout neurons. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 6176–6181.
73. Lauber, E., et al. Prenatal valproate exposure differentially affects parvalbumin-expressing neurons and related circuits in the cortex and striatum of mice. Front. Mol. Neurosci., 9, 2016, 150.
74. Han, S., et al. Enhancement of inhibitory neurotransmission by GABAA receptors having alpha2,3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron 81 (2014), 1282–1289.
75. Wohr, M., et al. Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities. Transl. Psychiatry, 5, 2015, e525.
76. Ito-Ishida, A., et al. Loss of MeCP2 in parvalbumin-and somatostatin-expressing neurons in mice leads to distinct Rett syndrome-like phenotypes. Neuron 88 (2015), 651–658.
77. Rapanelli, M., et al. Targeted interneuron depletion in the dorsal striatum produces autism-like behavioral abnormalities in male but not female mice. Biol. Psychiatry, 2017, 10.1016/j.biopsych.2017.01.020 Published online February 10, 2017.
78. Lopes, R., et al. Transcription factor LIM homeobox 7 (Lhx7) maintains subtype identity of cholinergic interneurons in the mammalian striatum. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 3119–3124.
79. Reiner, O., et al. Regulation of neuronal migration, an emerging topic in autism spectrum disorders. J. Neurochem. 136 (2016), 440–456.
80. Cobos, I., et al. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat. Neurosci. 8 (2005), 1059–1068.
81. Strauss, K.A., et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 354 (2006), 1370–1377.
82. Stoner, R., et al. Patches of disorganization in the neocortex of children with autism. N. Engl. J. Med. 370 (2014), 1209–1219.
83. Filice, F., et al. Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism. Mol. Brain, 9, 2016, 10.
84. Chohan, M.O., Moore, H., Interneuron progenitor transplantation to treat CNS dysfunction. Front. Neural Circuits, 10, 2016, 64.
85. Arber, C., Li, M., Cortical interneurons from human pluripotent stem cells: prospects for neurological and psychiatric disease. Front. Cell Neurosci., 7, 2013, 10.
86. Oki, K., et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 30 (2012), 1120–1133.
87. Tang, Y., et al. Cortical plasticity induced by transplantation of embryonic somatostatin or parvalbumin interneurons. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 18339–18344.
88. Fahim, C., et al. Somatosensory-motor bodily representation cortical thinning in Tourette: effects of tic severity, age and gender. Cortex 46 (2010), 750–760.
89. Mei, Y., et al. Adult restoration of Shank3 expression rescues selective autistic-like phenotypes. Nature 530 (2016), 481–484.